Hunan Er Kang Pharmaceutical (300267.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100001781
Hunan Er Kang Pharmaceutical financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.14 bn CNY | 1.17 bn CNY |
| Gross profit | 289.86 m CNY | 308.27 m CNY |
| Operating income | -370.61 m CNY | 15.71 m CNY |
| EBIT | -377.42 m CNY | -359.46 m CNY |
| Net income | -373.37 m CNY | -379.82 m CNY |
| Diluted EPS – continuing operations | -0.18 CNY | -0.18 CNY |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hunan Er Kang Pharmaceutical
Hunan Er-Kang Pharmaceutical Co., Ltd engages in the research and development, production, and sale of pharmaceutical excipients, APIs and finished drugs in China and internationally. The company offers various APIs, such as glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, dihydroxypropyl theophylline, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. It also provides finished drugs, including sulbenicillin sodium for injection and compound liquorice tablets. In addition, the company offers conventional pharmaceutical excipients, such as pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprising of hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate products. Hunan Er-Kang Pharmaceutical Co., Ltd was founded in 2003 and is based in Changsha, China.
More stocks
- FARMERS NATIONAL BANC CORP /OH/ (FMNB)
- Jiangxi Guoguang Commercial Chains Co Ltd (605188.SS)
- Altamir SCA (LTA.PA)
- Barings BDC, Inc. (BBDC)
- Odyssey Therapeutics, Inc. Common Stock (ODTX)
- Genuit Group PLC (GEN.L)
- Bloomin' Brands, Inc. (BLMN)
- KELLY SERVICES INC (KELYB)
- Whirlpool China Co Ltd (600983.SS)
- Syndax Pharmaceuticals Inc (SNDX)
- Brunner Investment Trust PLC (BUT.L)
- Workspace Group PLC (WKP.L)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.